Popular on eTradeWire
- - 248
- Blue Tide Car Wash Announces New Ownership as of April 1, 2025 - 212
- Nature-Based Printables Help Rhode Island Families Turn Beach Days into Learning Adventures - 200
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence - 138
- Aerial Survey Equipment Rental Expands: RIEGL VQ-1560 II-S for Rent Now Available Worldwide from AerialSurvey.com - 126
- Experience the Art of Flavor: CopaCity Salsa Launches Distinctive Smoked and Roasted Salsas - 122
- Mental and Emotional Self-Management, Practical Tools for Trauma-Informed Stress Management - 112
- A new global property platform with a twist has arrived, its name is U-SellBest.com or to the person that created it USB - 107
- Children's Author Chandra Donelson Hosts Book Signing at Barnes & Noble in Salem, NH - 106
- Robert Michael & Co. Real Estate Team Lists Pool Home in Hunters Creek, One of America's Top Places to Live - 104
Similar on eTradeWire
- Mend Colorado Reminds Boulder Residents of Expert Solutions for Back, Shoulder, and Knee Pain
- Don't Let a Lawsuit Take Away Everything: Attorney Blake Harris Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- Blake Harris the Leading Authority in International Asset Protection Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- Travera launches novel blood test for immunotherapy in cancer
- Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science
- Choosing the Right LN₂ Storage Tank
- EquityFax.com Launches to Deliver Institutional-Grade Stock Research to Main Street Investors
- Peter Fiorillo a Conspiracy Theory of Capital market valuations for 2025
- DigiByte (DGB) Eyes Coinbase Listing in July 2025 Amid Bitcoin Bull Run
- Applova x DRS Payments: seamless Clover payments
AI Team from "PersonalAIze" Expert Assessment; Groundbreaking AI Platform Starting with Early Cancer Detection: Renovaro; Stock Symbol: RENB
eTradeWire News/10781794
PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of the RENB RenovaroCube's advanced AI platform.
AMSTERDAM - eTradeWire -- Renovaro, Inc. (Stock Symbol: RENB) aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. RENB includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.
RENB RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective.
RENB RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.
Independent Expert Assessment Validates RENB RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
Assessment by specialist AI team from "PersonalAIze" Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform
PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of the RENB RenovaroCube's advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which the RENB RenovaroCube is based.
More on eTradeWire News
The RENB RenovaroCube AI platform has been advancing innovation for the past 12 years, evolving from its award-winning Fintech roots into a potentially groundbreaking multi-omic molecular differential system that identifies cancer in its earliest stages. It is an open platform that can be used as a SaaS by many private sector and academic or other large hospital and health systems. It is also disease agnostic, so it can be expanded for many purposes.
The initial aim for RENB is to transform cancer early detection and early detection of recurrence from a small vial of blood (liquid biopsy), potentially supporting clinicians to initiate treatments as soon as possible towards improved outcomes for patients.
Based on these findings, PersonalAIze is eager to collaborate further with RENB RenovaroCube to enhance and commercialize the platform.
This partnership for RENB could represent a substantial step forward in the fight against cancer, bringing together AI innovation and healthcare expertise to develop a powerful tool for early detection that has the potential to save countless lives.
RENB RenovaroCube Presented Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
RENB has presented two scientific presentations at a leading cancer conference – the European Society for Medical Oncology (ESMO) Congress – on September 15, 2024.
One RENB presentation describes the development of a deep learning model that leverages cell-free DNA (cfDNA) fragmentation features (fragmentomics) from a small sample of blood to detect cancer. The results show that in comparison to state-of-the-art cfDNA cancer detection models, we were able to perform on par while utilizing only minute amounts of genetic data. The integration of fragmentomics into the Cube's current platform, further enhances its capacity to detect cancer, potentially leading to earlier and/or better treatment options and improved patient outcomes.
More on eTradeWire News
A second RENB study demonstrated the Cube platform's ability to correlate methylation patterns from cancer tissue in cfDNA derived from plasma, indicating that cancer can be detected in blood samples as an alternative for invasive tissue biopsies.
To Review $RENB visit: http://www.renovarobio.com and https://compasslivemedia.com/renb/
Media Contact
Company Name: Renovaro Inc.
Contact Person: The Hon. Mark Dybul, MD, CEO
Company Websites: www.renovarobio.com
Email: ir@renovarobio.com
Phone: 732-780-5036
Home Country: United States
DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website
RENB RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective.
RENB RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.
Independent Expert Assessment Validates RENB RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
Assessment by specialist AI team from "PersonalAIze" Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform
PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of the RENB RenovaroCube's advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which the RENB RenovaroCube is based.
More on eTradeWire News
- Pyro Marketing Launches New Website to Accelerate Growth for Fitness Brands
- Nearly One Million Prisoner Engagements—"30in3" Campaign Near
- Morton Enclosures Boosts UL 891 & UL 508A Panel Support Across Texas–Southeast
- Mend Colorado Reminds Boulder Residents of Expert Solutions for Back, Shoulder, and Knee Pain
- Things to do in Vero Beach FL. This 2025 Summer
The RENB RenovaroCube AI platform has been advancing innovation for the past 12 years, evolving from its award-winning Fintech roots into a potentially groundbreaking multi-omic molecular differential system that identifies cancer in its earliest stages. It is an open platform that can be used as a SaaS by many private sector and academic or other large hospital and health systems. It is also disease agnostic, so it can be expanded for many purposes.
The initial aim for RENB is to transform cancer early detection and early detection of recurrence from a small vial of blood (liquid biopsy), potentially supporting clinicians to initiate treatments as soon as possible towards improved outcomes for patients.
Based on these findings, PersonalAIze is eager to collaborate further with RENB RenovaroCube to enhance and commercialize the platform.
This partnership for RENB could represent a substantial step forward in the fight against cancer, bringing together AI innovation and healthcare expertise to develop a powerful tool for early detection that has the potential to save countless lives.
RENB RenovaroCube Presented Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
RENB has presented two scientific presentations at a leading cancer conference – the European Society for Medical Oncology (ESMO) Congress – on September 15, 2024.
One RENB presentation describes the development of a deep learning model that leverages cell-free DNA (cfDNA) fragmentation features (fragmentomics) from a small sample of blood to detect cancer. The results show that in comparison to state-of-the-art cfDNA cancer detection models, we were able to perform on par while utilizing only minute amounts of genetic data. The integration of fragmentomics into the Cube's current platform, further enhances its capacity to detect cancer, potentially leading to earlier and/or better treatment options and improved patient outcomes.
More on eTradeWire News
- New Keylock Network Switch Enhances Cybersecurity for Critical Systems
- Happi Coffee Launches with a Mission to Bring Freshness, Simplicity, and Intention to Your Daily Cup
- Valerie's House Awards $37,000 in College Scholarships
- Local firm Launches QuickBooks Support to Help Small Businesses Streamline Finances and Boost Growth
- KCON LA 2025, 106.3 RAIN FM 'Take Over' Special Event
A second RENB study demonstrated the Cube platform's ability to correlate methylation patterns from cancer tissue in cfDNA derived from plasma, indicating that cancer can be detected in blood samples as an alternative for invasive tissue biopsies.
To Review $RENB visit: http://www.renovarobio.com and https://compasslivemedia.com/renb/
Media Contact
Company Name: Renovaro Inc.
Contact Person: The Hon. Mark Dybul, MD, CEO
Company Websites: www.renovarobio.com
Email: ir@renovarobio.com
Phone: 732-780-5036
Home Country: United States
DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website
Source: Corporate Ads
0 Comments
Latest on eTradeWire News
- New Book Executive One Chronicles the Visionary Leadership of Ernest E. Middleton, PhD
- Athlete Website Builder by TopFans Empowers Sports Professionals Worldwide
- What do a Police Officer, a Retiree, and an 8-Year-Old Girl have in Common?
- Manage Fan Subscriptions Platform Empowers Creators With Direct Fan Monetization
- Music Fan Engagement Platform TopFans Launches to Empower Musicians and Artists
- Anatomy Naturals Vintage-Inspired Body Skincare Powered by Jojoba Oil for Women 30+ and Modern Men
- PCnet's Cloud Services Strengthen Business Continuity and Disaster Recovery
- The Citizens Commission on Human Rights Annual Purple Heart Day Event will be Hosted at the Historic Fort Harrison
- Blake Harris the Leading Authority in International Asset Protection Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- Wise Business Plans Emerges as a Go-To Partner for Angel Investors, VCs, Family Offices and Private
- PR Brand Marketing Inc. Awarded GSA Multiple Award Schedule Contract with Strategic Support from Government Marketplace LLC
- Third Annual African American Cultural Expo and Children's Book Fair Comes to Waldorf, MD
- Premier Construction Business Brokers Announces the Addition of Consulting-Based Services
- Relativ receives AWS Education Equity Initiative Grant
- New Texas Symphony Orchestra Announces Dr. Michelle Perrin Blair as New Artistic Director for 2025-2026 Season
- First Generation and TechniCom Leadership Appointments Usher in a Bright Future
- Secrets in the Himalayas: Author K.A. Nayampalli Comes to Barnes & Noble Huntersville
- Travera launches novel blood test for immunotherapy in cancer
- Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science
- Entyre Solutions Launches to Support Senior Living Operators